Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype.
暂无分享,去创建一个
[1] L. Montanaro,et al. The basal‐like breast carcinoma phenotype is regulated by SLUG gene expression , 2008, The Journal of pathology.
[2] J. Clements,et al. Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression , 2007, Journal of cellular physiology.
[3] Carlos Caldas,et al. Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis , 2007, Nature Reviews Cancer.
[4] R. Weinberg,et al. Enrichment of a population of mammary gland cells that form mammospheres and have in vivo repopulating activity. , 2007, Cancer research.
[5] Alicia Zhou,et al. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers , 2007, Proceedings of the National Academy of Sciences.
[6] Héctor Peinado,et al. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.
[7] R. Beroukhim,et al. Molecular definition of breast tumor heterogeneity. , 2007, Cancer cell.
[8] E. Paish,et al. Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression , 2007, Histopathology.
[9] Wen-Lin Kuo,et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.
[10] J. Massagué,et al. Cancer Metastasis: Building a Framework , 2006, Cell.
[11] J. Benítez,et al. Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas , 2006, Journal of Clinical Pathology.
[12] Jos Jonkers,et al. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. , 2006, Cancer cell.
[13] Harikrishna Nakshatri,et al. CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis , 2006, Breast Cancer Research.
[14] Gema Moreno-Bueno,et al. Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition. , 2006, Cancer research.
[15] A. Rajasekaran,et al. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. , 2006, Cancer research.
[16] D. Easton,et al. Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast , 2006, Histopathology.
[17] F. Bertucci,et al. Gene expression profiling of breast cell lines identifies potential new basal markers , 2006, Oncogene.
[18] C. Fletcher,et al. Spindle Cell (Sarcomatoid) Carcinoma of the Breast: A Clinicopathologic and Immunohistochemical Analysis of 29 Cases , 2006, The American journal of surgical pathology.
[19] J. Benítez,et al. Prognostic Significance of Basal-Like Phenotype and Fascin Expression in Node-Negative Invasive Breast Carcinomas , 2006, Clinical Cancer Research.
[20] P. Eilers,et al. E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines , 2006, British Journal of Cancer.
[21] J. Thiery,et al. Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.
[22] G. Ball,et al. High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses , 2005, International journal of cancer.
[23] P. V. van Diest,et al. The origin of vimentin expression in invasive breast cancer: epithelial–mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential? , 2005, The Journal of pathology.
[24] D. Tarin,et al. The fallacy of epithelial mesenchymal transition in neoplasia. , 2005, Cancer research.
[25] D. Tarin,et al. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? , 2005, Cancer research.
[26] G. Berx,et al. The transcription factor snail induces tumor cell invasion through modulation of the epithelial cell differentiation program. , 2005, Cancer research.
[27] G. Berx,et al. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells , 2005, Oncogene.
[28] Keith R. Johnson,et al. Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition , 2005, Journal of Cell Science.
[29] Chiun-Sheng Huang,et al. p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components , 2004, The Journal of pathology.
[30] F. Portillo,et al. Transcriptional regulation of cadherins during development and carcinogenesis. , 2004, The International journal of developmental biology.
[31] A. Gown,et al. Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma , 2004, Clinical Cancer Research.
[32] S. Ramaswamy,et al. Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.
[33] Alan Mackay,et al. Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer. , 2004, Cancer research.
[34] R. Hazan,et al. Cadherin Switch in Tumor Progression , 2004, Annals of the New York Academy of Sciences.
[35] R. Walker,et al. Breast cell invasive potential relates to the myoepithelial phenotype , 2003, International journal of cancer.
[36] R. Tibshirani,et al. Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[37] P. Friedl,et al. Tumour-cell invasion and migration: diversity and escape mechanisms , 2003, Nature Reviews Cancer.
[38] M. Fraga,et al. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors , 2003, Journal of Cell Science.
[39] J. Thiery. Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.
[40] P. Savagner,et al. Leaving the neighborhood: molecular mechanisms involved during epithelial‐mesenchymal transition , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.
[41] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[42] M. Nieto,et al. A New Role for E12/E47 in the Repression ofE-cadherin Expression and Epithelial-Mesenchymal Transitions* , 2001, The Journal of Biological Chemistry.
[43] S. Ethier,et al. Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. , 2001, Cancer research.
[44] G. Berx,et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. , 2001, Molecular cell.
[45] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[46] Francisco Portillo,et al. The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression , 2000, Nature Cell Biology.
[47] J. Foidart,et al. Vimentin contributes to human mammary epithelial cell migration. , 1999, Journal of cell science.
[48] M. Webber,et al. Osteonectin promotes prostate cancer cell migration and invasion: a possible mechanism for metastasis to bone. , 1999, Cancer research.
[49] F. Matsumura,et al. Fascin, an actin-bundling protein, induces membrane protrusions and increases cell motility of epithelial cells. , 1998, Molecular biology of the cell.
[50] J. Davies. Epithelial-mesenchymal transitions , 1997 .